Andrew S. Levey, MD, BRCU Faculty
Andrew S. Levey, MD, is currently the Dr. Gerald J. and Dorothy R. Professor of Medicine at Tufts University School of Medicine and Chief, William B. Schwartz Division of Nephrology at Tufts Medical Center, and the Principal Investigator of the Division’s 15-year NIDDK grant (T32) “Epidemiology, Clinical Trials and Outcomes Research.” The research program is also funded, in part, by grants and contracts from foundations and industry. His research interests include measurement and estimation of kidney function, epidemiology of CKD, treatments to slow the progression of CKD, cardiovascular disease in CKD, nutrition in CKD, and assessment of outcomes in patients treated by dialysis and kidney transplantation. He was the principal nephrologist co-investigator for the NIDDK-sponsored Modification of Diet and Renal Disease (MDRD) Study. He and his colleagues have developed the MDRD Study equation to estimate GFR from serum creatinine using this large database, and more recently he has led the NIDDK-sponsored CKD Epidemiology Collaboration (CKD-EPI) to pool databases from other studies to develop the CKD-EPI equations based on creatinine, cystatin C and other filtration markers. He was a founding member of the Chronic Kidney Disease Prognosis Consortium (CKD-PC). The use of GFR estimating equations to estimate kidney function and inform prognosis has transformed research, clinical practice and public health in CKD.
Dr. Levey is a widely recognized authority on clinical practice guidelines in CKD. He led the National Kidney Foundation (NKF) Task Force on Cardiovascular Disease in 1998. He was the Chair for two NKF Kidney Disease Outcome Quality Initiative (KDOQI) Work Groups. “Chronic Kidney Disease: Evaluation, Classification and Stratification of Risk” was published in 2002. “Hypertension and Antihypertensive Agents in Chronic Kidney Disease” was published in 2004. He has led three Kidney Disease Improving Global Outcomes (KDIGO) conferences. The 2004 conference addressed definition and classification of CKD, the 2006 conference addressed public health approaches and initiatives, and the 2009 conference addressed prognosis. He participated on the KDIGO Work Groups for two KDIGO clinical practice guidelines, “Acute Kidney Injury” in 2011 and “Evaluation and Management of Chronic Kidney Disease” in 2013. He was Director of the Tufts Center on Guideline Development and Implementation from 2003 until 2011. He has received the Distinguished Faculty Award from Tufts University School of Medicine in 2004 and the Distinguished Alumnus Award from Boston University School of Medicine in 2013. The National Kidney Foundation has honored him with the President’s Award in 1998, Garabed Eknoyan Award in 2002, and David W. Hume Award in 2011. He was recipient of the Belding H. Scribner Award, presented on November 9, 2013 at the ASN Kidney Week in Atlanta, Georgia.